Jiang, Ying
Ray, Azizi
Junaid, Mohammad Shajid Ashraf
Bhattaccharjee, Sonalika Arup
Kelley, Kayla
Banga, Ajay K.
Blough, Bruce E.
Murnane, Kevin S. http://orcid.org/0000-0002-8143-0541
Funding for this research was provided by:
Georgia Research Alliance (GRA.VL17.11)
National Institute on Drug Abuse (DA12970)
Article History
First Online: 22 October 2019
Compliance with ethical standards
: All institutional and national guidelines for the care and use of laboratory animals were followed.
: None of the authors has a financial relationship with the sponsor of the research, which was the Georgia Research Alliance. The Georgia Research Alliance is a state government funded agency. Ajay Banga and Kevin Murnane are cofounders of DD Therapeutics, a for-profit startup company that aims to commercialize drug-delivery technology. Ajay Banga, Kevin Murnane, and Ying Jiang are co-inventors on a patent pending for transdermal use of phenethylamine monoamine releasers that is owned by Mercer University. Azizi Ray, Mohammad Shajid Ashraf Junaid, Sonalika Arup Bhattaccharjee, Kayla Kelley, and Bruce Blough have no conflicts of interest to declare.